| 000 | 03085nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 82231 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040402.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 141124s2015 gw | s |||| 0|eng d | ||
| 020 | _a9783319120096 | ||
| 024 | 7 |
_a10.1007/978-3-319-12009-6 _2doi |
|
| 050 | 4 |
_aQR46.5 _b2015 EB |
|
| 100 | 1 |
_aMandal, Sikha. _995025 _0Local |
|
| 245 | 1 | 0 |
_aExtremophilic Cyanobacteria For Novel Drug Development _cby Sikha Mandal, Jnanendra Rath. |
| 260 |
_aCham, Switzerland _bSpringer _c2015 |
||
| 300 |
_a1 recurso en línea (VII, 92 páginas) _b1 ilustraciones |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aSpringerBriefs in Pharmaceutical Science & Drug Development _x1864-8118 |
|
| 505 | 0 | _a1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria. | |
| 520 | 3 | _aThis volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aTecnología farmacéutica _0 _2embne _9161127 |
|
| 650 | 2 | 7 |
_aFarmacia _0 _2embne _9137891 |
| 700 | 1 |
_aRath, Jnanendra. _995026 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-12009-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b1290871x _b10-10-17 _c10-02-16 |
||
| 988 | _aSpringer_Medicine_2015 | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aQR46.5 M363 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1157639x _z06-04-17 |
||
| 999 |
_c82231 _d82231 _x1 |
||